ReviewPatient preference and adherence2019

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide.

Erminia Ridolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.